Entropy Neurodynamics Limited (ASX: ENP), a clinical-stage biotechnology company developing proprietary psilocin-based therapies, has secured a South African patent covering methods of treating fibromyalgia using psilocybin. The patent grant, issued under South African Patent No. 2025/01722, extends intellectual property protection until September 2043 and encompasses treatment methods, dosing regimens, patient selection criteria, clinical protocols and…